Health care providers' perceptions of the problems and causes of irrational use of drugs in two Middle East countries

International Journal of Clinical Practice

Volumn 60, Issue 5, 2006, Pages 565-570

  Otoom, Sameer A ^a,b   Sequeira, R P ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b UNIVERSITY OF BAHRAIN   (Bahrain)

Author keywords

Causes; Drugs; Irrational use; Jordan; Problems; Syria

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; GENERIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CONTINUING EDUCATION; CONTROLLED STUDY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIARRHEA; DRUG MISUSE; DRUG UTILIZATION; GENERAL PRACTITIONER; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH PERSONNEL ATTITUDE; HUMAN; JORDAN; MEDICAL DECISION MAKING; MEDICAL RECORD; MIDDLE EAST; PATIENT EDUCATION; PHARMACIST ATTITUDE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF MEDICATION; SYRIAN ARAB REPUBLIC; UPPER RESPIRATORY TRACT INFECTION; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; ANTIDIARRHEALS; ATTITUDE OF HEALTH PERSONNEL; DRUG THERAPY; DRUG UTILIZATION; HEALTH SERVICES MISUSE; HUMANS; JORDAN; PRESCRIPTIONS, DRUG; SYRIA;

EID: 33646250201     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00808.x     Document Type: Article

References (24)

1. Hogerzeil HV, Walker GJ, Sallami AO, Fernando G. Impact of an essential drugs programme on availability and rational use of drugs. Lancet 1989; 1: 141-2.
2. Quick J, Laing R, Ross-Degnan D. Intervention research to promote clinically effective and economically efficient use of pharmaceuticals: the international network for rational use of drugs. J Clin Epidemiol 1991; 44: 57-65.
3. Laing RO. Rational drug use: Unsolved problem. Tropical Doctor 1990; 20: 101-3.
4. World Health Organization/Regional Office of the Eastern Mediterranean country profiles. Available at: http://www.emro.who.int/ CountryProfiles-syr.htm
5. World Health Organization/Regional Office of the Eastern Mediterranean country profiles. Available at: http://www.emro.who.int/ CountryProfiles-jor.htm
6. Otoom S, Batieha A, Hadidi H, Hasan M, Al-Saudi K. Evaluation of drug use in Jordan using WHO patient care and health facility indicators. East Mediterr Health J 2002; 8: 544-9.
7. Otoom S, Batieha A, Hadidi H, Hasan M, Al-Saudi K. Evaluation of drug use in Jordan using WHO prescribing indicators. East Mediterr Health J 2002; 8: 537-43.
8. The WHO collaborative National drug policies based on essential drugs including quality control. Available at: http://www.emro.who.int/jordan/ collaborativeProg-DrugPolicy.htm
9. Drug Information Bulletin of Syria, 5th edn, 2003.
10. Jordan Drug Directorate. Available at: http://www.drugdirect.gov.jo/ english/section.shtm
11. Jordan pharmaceutical association. Available at: http://www.jpa.org.jo/
12. A draft of National Drug policy of Syrian Arab Republic, Ministry of Health, 1994.
13. Hashemite Kingdom of Jordan, National Drug Policy. National Drug Policy Management & Implementation Department, Drug Directorate, Ministry of Health, Jordan, 2002.
14. Laing RO, Ross-Degnan DG. National drug policies. Lancet 1995; 346: 1561-2.
15. Laing RO, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan 2001; 16: 13-20.
16. Quick JD, Laing RO, Ross-Degnan DG. Intervention research to promote clinically effective and economically efficient use of pharmaceuticals: the International Network for Rational Use of Drugs. J Clin Epidemiol 1991; 44 (Suppl. 2): 57S-65S.
17. WHO. How to Investigate Drug Use in Health Facilities (Selected Drug Use Indicators). WHO/DAP/93.1. Geneva: World Health Organization, 1993.
18. WHO. The Use of Essential Drugs. Technical Report Series 867. Geneva: World Health Organization, 1997.
19. Mabadeje AF, Akintonwa AA, Ashorobi RB. The value and effects of implementing an essential drugs list in the Lagos University Teaching Hospital. Clin Pharmacol Ther 1991; 50: 121-4.
20. The National Drug List of Syrian Arab Republic, 5th edn, 2004.
21. Essential Drug List for the Different Health Care Levels. Drug Directorate, Ministry of Health, The Hashemite Kingdom of Jordan, 2001.
22. International conference on national medicinal policies-the way forward. Aust Prescr 1997; 20 (Suppl. 1): 51-272.
23. WHO. Guidelines or National Drug Policies. Geneva: World Health Organization, 1988.
24. WHO. Revision of Undergraduate Pharmacy Curricula. Report of an informal consultation in Nyanga, Zimbabwe 18-20 April 1997. WHO/DAP/98.1. Geneva: World Health Organization.